These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28714209)

  • 1. Biotransporting Self-Assembled Nanofactories Using Polymer Vesicles with Molecular Permeability for Enzyme Prodrug Cancer Therapy.
    Nishimura T; Sasaki Y; Akiyoshi K
    Adv Mater; 2017 Sep; 29(36):. PubMed ID: 28714209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotransporting Biocatalytic Reactors toward Therapeutic Nanofactories.
    Nishimura T; Akiyoshi K
    Adv Sci (Weinh); 2018 Nov; 5(11):1800801. PubMed ID: 30479925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-dilated polymersome nanofactories for enhanced enzyme prodrug chemo-immunotherapy.
    Japir AAMM; Ke W; Li J; Mukerabigwi JF; Ibrahim A; Wang Y; Li X; Zhou Q; Mohammed F; Ge Z
    J Control Release; 2021 Nov; 339():418-429. PubMed ID: 34662586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymersome nanoreactors with tumor pH-triggered selective membrane permeability for prodrug delivery, activation, and combined oxidation-chemotherapy.
    Mukerabigwi JF; Yin W; Zha Z; Ke W; Wang Y; Chen W; Japir AAMM; Wang Y; Ge Z
    J Control Release; 2019 Jun; 303():209-222. PubMed ID: 31026547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermoresponsive Carbohydrate-
    Okuno Y; Nishimura T; Sasaki Y; Akiyoshi K
    Biomacromolecules; 2021 Jul; 22(7):3099-3106. PubMed ID: 34165283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
    Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
    Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of PolyMPC-Dox Prodrugs in a Human Ovarian Tumor Model.
    Wong KE; Mora MC; Skinner M; McRae Page S; Crisi GM; Arenas RB; Schneider SS; Emrick T
    Mol Pharm; 2016 May; 13(5):1679-87. PubMed ID: 27023764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination.
    Satchi-Fainaro R; Hailu H; Davies JW; Summerford C; Duncan R
    Bioconjug Chem; 2003; 14(4):797-804. PubMed ID: 12862433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pH-responsive prodrug delivery system self-assembled from acid-labile doxorubicin-conjugated amphiphilic pH-sensitive block copolymers.
    Huang X; Liao W; Xie Z; Chen D; Zhang CY
    Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():27-37. PubMed ID: 29853091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer Prodrug-Based Nanoreactors Activated by Tumor Acidity for Orchestrated Oxidation/Chemotherapy.
    Li J; Li Y; Wang Y; Ke W; Chen W; Wang W; Ge Z
    Nano Lett; 2017 Nov; 17(11):6983-6990. PubMed ID: 28977746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles.
    Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W
    Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel.
    Sun J; Chen Y; Li K; Huang Y; Fu X; Zhang X; Zhao W; Wei Y; Xu L; Zhang P; Venkataramanan R; Li S
    Acta Biomater; 2016 Oct; 43():282-291. PubMed ID: 27422196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate-Sorting Nanoreactors Based on Permeable Peptide Polymer Vesicles and Hybrid Liposomes with Synthetic Macromolecular Channels.
    Nishimura T; Hirose S; Sasaki Y; Akiyoshi K
    J Am Chem Soc; 2020 Jan; 142(1):154-161. PubMed ID: 31766845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Nanoreactors as In Vivo Nanoplatforms for Cancer Therapy.
    Mukerabigwi JF; Ge Z; Kataoka K
    Chemistry; 2018 Oct; 24(59):15706-15724. PubMed ID: 29572992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pendant HDAC inhibitor SAHA derivatised polymer as a novel prodrug micellar carrier for anticancer drugs.
    Xu J; Sun J; Wang P; Ma X; Li S
    J Drug Target; 2018; 26(5-6):448-457. PubMed ID: 29251528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier.
    Sun JJ; Chen YC; Huang YX; Zhao WC; Liu YH; Venkataramanan R; Lu BF; Li S
    Acta Pharmacol Sin; 2017 Jun; 38(6):823-834. PubMed ID: 28504251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Semiconducting Polymer Nano-prodrug for Hypoxia-Activated Photodynamic Cancer Therapy.
    Cui D; Huang J; Zhen X; Li J; Jiang Y; Pu K
    Angew Chem Int Ed Engl; 2019 Apr; 58(18):5920-5924. PubMed ID: 30793456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel glucosylceramide synthase inhibitor based prodrug copolymer micelles for delivery of anticancer agents.
    Xu J; Zhao W; Sun J; Huang Y; Wang P; Venkataramanan R; Yang D; Ma X; Rana A; Li S
    J Control Release; 2018 Oct; 288():212-226. PubMed ID: 30223045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable Biocatalytic Nanocomposite Hydrogel Factories for Focal Enzyme-Prodrug Cancer Therapy.
    Ono K; Hashimoto H; Katayama T; Ueda N; Nagahama K
    Biomacromolecules; 2021 Oct; 22(10):4217-4227. PubMed ID: 34546743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic nanoreactors: combining chemistry and biology in a novel triblock copolymer drug delivery system.
    Ranquin A; Versées W; Meier W; Steyaert J; Van Gelder P
    Nano Lett; 2005 Nov; 5(11):2220-4. PubMed ID: 16277457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.